Speaker
Chief Scientific Officer, Dewpoint Therapeutics
Ann Boija, Chief Scientific Officer at Dewpoint Therapeutics, spoke at 9th RNA-Targeted Drug Discovery & Development Summit (Boston, United States of America, 10–12 Nov 2026) in the session “Advancing First-in-Class Condensate Modulators for Previously Inaccessible Targets”.
10–12 Nov 2026Boston, United States of America
Associate Director, Early Discovery Chemistry, PTC Therapeutics
Professor & Associate Chair of Graduate Affairs, University of Colorado Boulder
Head of Cancer Biology, EPICS Therapeutics
Senior Principal Scientist & Research Fellow, Pfizer
Head of Small Molecules Medicinal Chemistry, Sanofi
Chief Executive Officer, Renasis Bio
This profile is built from conference programmes published on kongre.net. It has not been claimed or confirmed by Ann Boija, and it lists only the talks, sessions and presentations named in those programmes.
Is this you? Claim this profile — every request is read by a person before anything is linked.
To ask for a correction or for this profile to be removed, email [email protected].